Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Andrea Benedetti, Mênonli Adjobimey et al.|New England Journal of Medicine|2018Cited by 392
Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative DataJoseph H. Puyat, James C. Johnston, Dick Menzies et al.|Clinical Infectious Diseases|2024Cited by 8